Product
WRAIR-PAM-CF1
1 clinical trial
2 indications
Indication
Bacterial InfectionIndication
Cystic FibrosisClinical trial
A Phase 1b/2, Multi-Centered, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Microbiological Activity of a Single Dose of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas AeruginosaStatus: Recruiting, Estimated PCD: 2024-06-28